United States · FDA National Drug Code directory
XELODA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61269-475_32dd0155-c5cb-49c2-9b74-74f40df22df7
- Product NDC
- 61269-475
- Form
- TABLET, FILM COATED
- Composition / generic term
- capecitabine
- Labeler
- H2-Pharma, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19980430
- Source listing expiry
- 20271231
Source-listed ingredients
- CAPECITABINE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61269-475-12) · 61269-475-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →